FR2262976A1 - Xanthinoxidase-inhibitory substd. formamidrazones - prepd. by reacting 4-pyrimidinone and amine - Google Patents

Xanthinoxidase-inhibitory substd. formamidrazones - prepd. by reacting 4-pyrimidinone and amine

Info

Publication number
FR2262976A1
FR2262976A1 FR7506629A FR7506629A FR2262976A1 FR 2262976 A1 FR2262976 A1 FR 2262976A1 FR 7506629 A FR7506629 A FR 7506629A FR 7506629 A FR7506629 A FR 7506629A FR 2262976 A1 FR2262976 A1 FR 2262976A1
Authority
FR
France
Prior art keywords
methyl
pentamethylene
ethyl
esp
formamidrazones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7506629A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of FR2262976A1 publication Critical patent/FR2262976A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

N-Acyl-N''-(3-amino-2-cyano-acryloyl) formamidrazones of formula (I) : and their tautomers and salts with (in)org. acids (in which R1 and R2 are same or different H or opt. branched 1-7C alkyl, with proviso that R1 and R2 are not both H, R1+R2 may form 2-5C alkylene in which one methylene group is opt. replaced by -O, -S or -NR7 forming . e.g. 3-aza-, 3-thia-, 3-oxo-pentamethylene and pentamethylene, R1 and R2 are pref. methyl or together from 3-oxo-pentamethylene R7=H or 1-7C alkyl; R3 = 4- N,N-dipropylsulphamoyl - phenyl, pyridyl-(3), pyridyl-(4), 1,3,5-triphenylpyrazolyl -(4) -methyl, 1,2,3,6-tetrahydro-2,6-dioxopyrimidinyl-(4), thiazolidinyl-(4), 1- 6-methoxynaphthyl-(2) -ethyl, 1-methyl-1-(4- 1,2,3,4-tetrahydronaphthyl-(1) -phenoxy) -ethyl, (3-trifluoromethyl phenoxy)-(4-chlorophenyl)-methyl, 3-acetyl-thiazoliol-inyl-(4) and esp. 1-methyl-1-(4-chlorophenoxy)-ethyl) have xanthinoxidase inhibitory activity and may be used against gout, coronary insufficiency and anti-arrhythmia. Depending on R3 cpds. (I) also have lipid-lowering-, uricosuric-, antiphlogistic-, esp. anti-rheumatic- and liver-protecting activity. (I) are also inters. for other active cpds. such as 4(1H)-pyrimidinones used esp. against gout.
FR7506629A 1974-03-04 1975-03-04 Xanthinoxidase-inhibitory substd. formamidrazones - prepd. by reacting 4-pyrimidinone and amine Withdrawn FR2262976A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK115374A DK115374A (en) 1974-03-04 1974-03-04

Publications (1)

Publication Number Publication Date
FR2262976A1 true FR2262976A1 (en) 1975-10-03

Family

ID=8101605

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7506629A Withdrawn FR2262976A1 (en) 1974-03-04 1975-03-04 Xanthinoxidase-inhibitory substd. formamidrazones - prepd. by reacting 4-pyrimidinone and amine

Country Status (4)

Country Link
BE (1) BE826258A (en)
DE (1) DE2509049A1 (en)
DK (1) DK115374A (en)
FR (1) FR2262976A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
GB860303A (en) 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
DE1904894U (en) 1964-03-28 1964-11-19 Karl Dipl Ing Gruendig CARRYING AND FASTENING DEVICE FOR SAFETY BELTS.
US3517050A (en) 1966-10-03 1970-06-23 Merck & Co Inc Ester and amide derivative of (3-trifluoromethylphenoxy) (4 - halophenyl)acetic acid
GB1252435A (en) 1968-02-02 1971-11-03
AT289743B (en) 1968-10-08 1971-05-10 Byk Gulden Lomberg Chem Fab Process for the preparation of 1-dimethylamino-2-cyano-chloro-4-azapenta-1,3-diene-5-dimethylimmonium perchlorate
BE755924A (en) 1969-09-12 1971-02-15 Byk Gulden Lomberg Chem Fab PYRAZOLE-4-ACETIC ACID DERIVATIVES, THEIR PROCESS OF PREPARATION AND MEDICINAL PRODUCTS CONTAINING
LU66036A1 (en) 1972-09-08 1974-03-14

Also Published As

Publication number Publication date
DE2509049A1 (en) 1975-09-11
BE826258A (en) 1975-09-04
DK115374A (en) 1975-11-03

Similar Documents

Publication Publication Date Title
ES413809A1 (en) 1,4-Dihydropyridine carboxylic acid esters
ES409907A1 (en) Imidazolyl-(2)-carbinols having hypolipidemic action and process for preparing them
DK303481A (en) METHOD OF PREPARING AMIDES OF HYDROXYPHENYL-ALKYLAMINOETANOLS OR THERAPEUTICALLY ACCEPTABLE SALTS THEREOF
ES8300104A1 (en) Benzopyrans, their production and pharmaceutical compositions containing them.
GB1425354A (en) Indole derivatives
GB1153578A (en) Phenyl-Isopropylamine Derivatives
FR2262976A1 (en) Xanthinoxidase-inhibitory substd. formamidrazones - prepd. by reacting 4-pyrimidinone and amine
GB1188154A (en) New Pyridine Derivatives and process for their preparation
BR7408315D0 (en) PROCESS IMPROVEMENT FOR THE SYNTHESIS OF A C1-C7 ALIFACTIC HYDROCARBILE ESTER OF AN N- (2,6-DI (C1-C7 ALKYL) FENIL) ALPHA-AMINOCARBOXYLIC ACID
ES429671A1 (en) Certain 2,3-dihydrobenzofuranyl esters of certain N-sulfenylated carbamic acids
ATE52778T1 (en) SUBSTITUTED AZOLYLCYCLOPROPYL-AZOLYLMETHYLCARBINOL DERIVATIVES.
ATE47135T1 (en) ANTICONVULSE AGENTS.
FR2262977A1 (en) Xanthinoxidase-inhibitory-hydrazomomethyl-substd.-pentadiene nitriles - prepd. by reacting 3-ethoxy-2-cyano-N-formylacrylamide with acid hydrazide
GB1260227A (en) Cosmetic compositions
GB1426479A (en) Dermatological composition and method
GB1255751A (en) Herbicidal agents
ES435200A1 (en) 1-imidazoyl-methanephosphonic acid esters
ES8306372A1 (en) Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom
ES429328A1 (en) N-substituted glycinates
GB1329908A (en) Pyridine derivatives
ES442009A1 (en) Method of treating fungus-infected plants with phenylazocyanoacetic ester derivatives
SU527127A3 (en) Herbicide
GB1455169A (en) Amidic derivatives of nicotinic acid
ES398146A1 (en) Substituted phosphoramide compounds and their conversion to substituted benzamide derivatives
FR2279383A1 (en) N-(4,4-diphenyl-butyl)-substd alkylene-diamines - cardiovascular agents suitable for treatment of angina

Legal Events

Date Code Title Description
ST Notification of lapse